Therefore, reduced NKG2D may be associated with the reduced NK cell cytotoxic activity previously shown in severe CFS/ME patients compared to moderate CFS/ME patients [4, 10]. This evidence concerns the gene KLRK1 and myalgic encephalomeyelitis/chronic fatigue syndrome.